AtriCure (ATRC) Other Non-Current Assets (2010 - 2026)
AtriCure's (ATRC) quarterly Other Non-Current Assets came in at $4.6 million in Q2 2026, up 63.76% year-over-year from $2.8 million in Q2 2025, and up 24.27% quarter-over-quarter from $3.7 million in Q1 2026.
Analysis
AtriCure (ATRC) Other Non-Current Assets (2010 - 2026) Analysis & Trends
AtriCure (ATRC) has reported Other Non-Current Assets for 17 consecutive years, with $4.6 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other Non-Current Assets rose 63.76% year-over-year to $4.6 million in Q2 2026; TTM through Jun 2026 was $4.6 million, a 63.76% increase from a year earlier, with the FY2025 full-year figure at $2.9 million, changed 0.14% from the prior year.
- Other Non-Current Assets was $4.6 million for Q2 2026 at AtriCure, up from $3.7 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $4.6 million in Q2 2026 and troughed at $685000.0 in Q1 2022.
- A 5-year average of $2.4 million and a median of $2.8 million in 2025 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets declined 21.42% in 2022 and soared 136.5% in 2023, its largest moves.
- Over 5 years, Other Non-Current Assets stood at $2.0 million in 2022, then increased by 8.82% to $2.2 million in 2023, then soared by 32.78% to $2.9 million in 2024, then fell by 0.14% to $2.9 million in 2025, then soared by 59.99% to $4.6 million in 2026.
- The last three Other Non-Current Assets figures came in at $4.6 million (Q2 2026), $3.7 million (Q1 2026), and $2.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 4.32 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 3.23 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 616.40 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 434.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 273.70 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 215.10 Mn |
| 10 | AtriCure | 2.58 Bn | 2.41 Bn | 118.63 Mn | 4.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.58 Mn |
| Mar 31, 2026 | 3.69 Mn |
| Dec 31, 2025 | 2.86 Mn |
| Sep 30, 2025 | 3.06 Mn |
| Jun 30, 2025 | 2.80 Mn |
| Mar 31, 2025 | 2.80 Mn |
| Dec 31, 2024 | 2.87 Mn |
| Sep 30, 2024 | 3.01 Mn |
| Jun 30, 2024 | 3.20 Mn |
| Mar 31, 2024 | 3.27 Mn |
| Dec 31, 2023 | 2.16 Mn |
| Sep 30, 2023 | 1.64 Mn |
| Jun 30, 2023 | 1.54 Mn |
| Mar 31, 2023 | 1.62 Mn |
| Dec 31, 2022 | 1.99 Mn |
| Sep 30, 2022 | 829,000.00 |
| Jun 30, 2022 | 804,000.00 |
| Mar 31, 2022 | 685,000.00 |
| Dec 31, 2021 | 955,000.00 |
| Sep 30, 2021 | 1.06 Mn |